US Stock MarketDetailed Quotes

Alaunos Therapeutics (TCRT)

Watchlist
  • 2.810
  • +0.070+2.55%
Close Jan 15 16:00 ET
  • 2.870
  • +0.060+2.12%
Post 20:01 ET
6.27MMarket Cap-1.22P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alaunos Therapeutics (TCRT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
100.00%2K
100.00%10K
300.00%4K
0
0.00%4K
1K
-99.83%5K
-90.91%1K
Operating revenue
--0
--0
100.00%2K
100.00%10K
300.00%4K
--0
0.00%4K
--1K
-99.83%5K
-90.91%1K
Cost of revenue
Gross profit
Operating expense
3.22%1.19M
-11.20%1.04M
-37.23%1.09M
-83.08%4.82M
-77.42%759K
-84.10%1.15M
-85.79%1.17M
-81.98%1.74M
-25.32%28.5M
-60.61%3.36M
Selling and administrative expenses
-28.70%718K
-13.74%854K
-53.80%747K
-63.50%4.46M
-65.20%845K
-71.86%1.01M
-67.49%990K
-48.96%1.62M
-7.02%12.22M
-16.99%2.43M
-General and administrative expense
-28.70%718K
-13.74%854K
----
-63.50%4.46M
-65.20%845K
-71.86%1.01M
-67.49%990K
----
-7.02%12.22M
-16.99%2.43M
Research and development costs
227.97%469K
2.78%185K
175.40%347K
-97.78%362K
-109.22%-86K
-96.09%143K
-96.53%180K
-98.06%126K
-34.93%16.28M
-83.36%933K
Operating profit
-3.22%-1.19M
10.89%-1.04M
37.31%-1.09M
83.11%-4.81M
77.53%-755K
84.10%-1.15M
85.83%-1.17M
81.99%-1.74M
19.14%-28.49M
60.57%-3.36M
Net non-operating interest income expense
0
0
0
0
0
39.09%-1.92M
0
Non-operating interest expense
----
----
----
--0
--0
--0
--0
--0
-39.09%1.92M
--0
Other net income (expense)
21.74%28K
-132.43%-12K
-68.33%19K
102.81%133K
100.29%13K
101.85%23K
-92.91%37K
-87.42%60K
-813.90%-4.73M
-1,893.20%-4.48M
Gain on sale of security
----
---31K
----
----
----
----
----
----
----
----
Special income (charges)
----
----
----
--0
--0
--0
--0
----
-4,441.35%-5.77M
---4.59M
-Less：Restructuring and merger&acquisition
----
----
----
--0
--0
--0
----
----
--1.27M
--850K
-Less:Impairment of capital assets
----
----
----
--0
--0
--0
----
----
--4.8M
--3.79M
-Less:Other special charges
----
----
----
----
----
----
----
----
-124.06%-298K
---53K
Other non- operating income (expenses)
21.74%28K
-48.65%19K
-68.33%19K
-87.31%133K
-87.74%13K
-87.77%23K
-86.64%37K
-87.42%60K
98.11%1.05M
-57.60%106K
Income before tax
-2.84%-1.16M
6.91%-1.05M
36.21%-1.07M
86.68%-4.68M
90.54%-742K
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
Income tax
Net income
-2.84%-1.16M
6.91%-1.05M
36.21%-1.07M
86.68%-4.68M
90.54%-742K
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
Net income continuous Operations
-2.84%-1.16M
6.91%-1.05M
36.21%-1.07M
86.68%-4.68M
90.54%-742K
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
Minority interest income
Net income attributable to the parent company
-2.84%-1.16M
6.91%-1.05M
36.21%-1.07M
86.68%-4.68M
90.54%-742K
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2.84%-1.16M
6.91%-1.05M
36.21%-1.07M
86.68%-4.68M
90.54%-742K
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
Basic earnings per share
21.43%-0.55
11.27%-0.63
36.19%-0.67
86.71%-2.92
90.61%-0.46
86.79%-0.7
87.07%-0.71
83.33%-1.05
94.39%-21.97
18.33%-4.9
Diluted earnings per share
21.43%-0.55
11.27%-0.63
36.19%-0.67
86.71%-2.92
90.61%-0.46
86.79%-0.7
87.07%-0.71
83.33%-1.05
94.39%-21.97
18.33%-4.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00100.00%2K100.00%10K300.00%4K00.00%4K1K-99.83%5K-90.91%1K
Operating revenue --0--0100.00%2K100.00%10K300.00%4K--00.00%4K--1K-99.83%5K-90.91%1K
Cost of revenue
Gross profit
Operating expense 3.22%1.19M-11.20%1.04M-37.23%1.09M-83.08%4.82M-77.42%759K-84.10%1.15M-85.79%1.17M-81.98%1.74M-25.32%28.5M-60.61%3.36M
Selling and administrative expenses -28.70%718K-13.74%854K-53.80%747K-63.50%4.46M-65.20%845K-71.86%1.01M-67.49%990K-48.96%1.62M-7.02%12.22M-16.99%2.43M
-General and administrative expense -28.70%718K-13.74%854K-----63.50%4.46M-65.20%845K-71.86%1.01M-67.49%990K-----7.02%12.22M-16.99%2.43M
Research and development costs 227.97%469K2.78%185K175.40%347K-97.78%362K-109.22%-86K-96.09%143K-96.53%180K-98.06%126K-34.93%16.28M-83.36%933K
Operating profit -3.22%-1.19M10.89%-1.04M37.31%-1.09M83.11%-4.81M77.53%-755K84.10%-1.15M85.83%-1.17M81.99%-1.74M19.14%-28.49M60.57%-3.36M
Net non-operating interest income expense 0000039.09%-1.92M0
Non-operating interest expense --------------0--0--0--0--0-39.09%1.92M--0
Other net income (expense) 21.74%28K-132.43%-12K-68.33%19K102.81%133K100.29%13K101.85%23K-92.91%37K-87.42%60K-813.90%-4.73M-1,893.20%-4.48M
Gain on sale of security -------31K--------------------------------
Special income (charges) --------------0--0--0--0-----4,441.35%-5.77M---4.59M
-Less：Restructuring and merger&acquisition --------------0--0--0----------1.27M--850K
-Less:Impairment of capital assets --------------0--0--0----------4.8M--3.79M
-Less:Other special charges ---------------------------------124.06%-298K---53K
Other non- operating income (expenses) 21.74%28K-48.65%19K-68.33%19K-87.31%133K-87.74%13K-87.77%23K-86.64%37K-87.42%60K98.11%1.05M-57.60%106K
Income before tax -2.84%-1.16M6.91%-1.05M36.21%-1.07M86.68%-4.68M90.54%-742K86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M
Income tax
Net income -2.84%-1.16M6.91%-1.05M36.21%-1.07M86.68%-4.68M90.54%-742K86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M
Net income continuous Operations -2.84%-1.16M6.91%-1.05M36.21%-1.07M86.68%-4.68M90.54%-742K86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M
Minority interest income
Net income attributable to the parent company -2.84%-1.16M6.91%-1.05M36.21%-1.07M86.68%-4.68M90.54%-742K86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2.84%-1.16M6.91%-1.05M36.21%-1.07M86.68%-4.68M90.54%-742K86.70%-1.13M87.13%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M
Basic earnings per share 21.43%-0.5511.27%-0.6336.19%-0.6786.71%-2.9290.61%-0.4686.79%-0.787.07%-0.7183.33%-1.0594.39%-21.9718.33%-4.9
Diluted earnings per share 21.43%-0.5511.27%-0.6336.19%-0.6786.71%-2.9290.61%-0.4686.79%-0.787.07%-0.7183.33%-1.0594.39%-21.9718.33%-4.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -